Skip to main content
Published locations for Ulcerative colitis study: Ozanimod tops adalimumab, equals vedolizumab
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Ulcerative colitis study: Ozanimod tops adalimumab, equals vedolizumab
User login
Username
Password
Reset your password
/content/ulcerative-colitis-study-ozanimod-tops-adalimumab-equals-vedolizumab
/internalmedicinenews/article/248939/gastroenterology/ulcerative-colitis-study-ozanimod-tops
/internalmedicine/article/248939/gastroenterology/ulcerative-colitis-study-ozanimod-tops-adalimumab